Association of Renin-Angiotensin Inhibitor Treatment With Mortality and Heart Failure Readmission in Patients With Transcatheter Aortic Valve Replacement

IMPORTANCE: Data are lacking on the effect of a renin-angiotensin system (RAS) inhibitor prescribed after transcatheter aortic valve replacement (TAVR). Treatment with a RAS inhibitor may reverse left ventricular remodeling and improve function. OBJECTIVE: To investigate the association of prescript...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:JAMA
Prif Awduron: Inohara, Taku, Manandhar, Pratik, Kosinski, Andrzej S., Matsouaka, Roland A., Kohsaka, Shun, Mentz, Robert J., Thourani, Vinod H., Carroll, John D., Kirtane, Ajay J., Bavaria, Joseph E., Cohen, David J., Kiefer, Todd L., Gaca, Jeffrey G., Kapadia, Samir R., Peterson, Eric D., Vemulapalli, Sreekanth
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: American Medical Association 2018
Pynciau:
Original Investigation
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6583475/
https://ncbi.nlm.nih.gov/pubmed/30512100
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jama.2018.18077
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg